Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50%: EMPOWER-Lung 1 subgroup analysis.

Ozguroglu M., Sezer A., Kilickap S., Gumus M., Bondarenko I., Gogishvili M., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (Peer-Reviewed Journal) identifier

  • Publication Type: Article / Abstract
  • Volume: 39 Issue: 15
  • Publication Date: 2021
  • Doi Number: 10.1200/jco.2021.39.15_suppl.9085
  • Journal Name: JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database